Fluid management in liposuction
The most common error is to treat the aspirate as blood loss and replace it accordingly. With the wet or tumescent technique the aspirate is largely wetting solution. Fluid overload is the complication most consistently reported in the published series.
Replacement is governed by a total-aspirate threshold. The local anesthetic dose sets a second limit, with a risk window that extends beyond discharge. The wetting solution counts as intake; additional crystalloid is calculated only on the volume above the threshold, and monitoring covers the absorption period.
1. Intravascular absorption of the wetting solution
Wetting solution infiltrated into the subcutaneous tissue enters the intravascular compartment: 50% to 70% of the volume is absorbed, and absorption continues for hours after the procedure ends.
- The aspirate is not replaced volume for volume.
- Overload becomes apparent after discharge from the PACU.
- Hemoglobin over the first 24 hours reflects dilution as well as loss: where bleeding has been minimal, a fall of 2 g/dL does not warrant a search for occult hemorrhage until hemodilution has been considered.
2. Infiltration technique, fluid intake and blood content of the aspirate
The first thing the anesthesiologist needs to know is the planned infiltration ratio: it determines both the fluid intake and the blood fraction of the aspirate.
| Technique | Infiltration volume | Blood in the aspirate |
|---|---|---|
| Dry | None | 20% to 45% |
| Wet | 200 to 300 mL per area | 4% to 30% |
| Superwet | 1 mL per mL of fat to be removed | 1% to 4% |
| Tumescent | 3 to 4 mL per mL of anticipated aspirate | 1% or less |
With the superwet or tumescent technique, the blood content of a 5,000 mL aspirate is of the order of 50 mL; the limiting variables are fluid intake and the total local anesthetic dose.
3. Calculating replacement
The reference figures come from two successive publications by the same group; the second revised the threshold after mild overhydration was observed with the first.
| Reference | Threshold | Intake |
|---|---|---|
| Trott et al., 1998 | 4,000 mL | Below: maintenance plus the wetting solution. Above: add 0.25 mL of IV crystalloid per mL above the threshold. Intraoperative fluid ratio: 2.1 in low-volume cases, 1.4 in high-volume cases. |
| Rohrich et al., 2006 | 5,000 mL | Same scheme, applied to the new threshold. |
The 0.25 applies only to the volume above the threshold, not to the total aspirate. In an 8,000 mL procedure, calculating on the total gives 2,000 mL of additional crystalloid; calculating on the excess gives 750 mL. The error multiplies the additional crystalloid by 2.7 and raises the risk of overload.
Worked example: 70 kg, total aspirate 6,000 mL, superwet technique, 3 hours
| Component | Calculation | Volume |
|---|---|---|
| Maintenance | 2 mL/kg/h for 3 h | 420 mL (IV) |
| Wetting solution absorbed | 50% to 70% of 6,000 mL | 3,000 to 4,200 mL (SC) |
| Additional for volume above threshold | (6,000 − 5,000) × 0.25 | 250 mL (IV) |
| Effective volume received | 3,670 to 4,870 mL |
The IV component totals 670 mL; the remainder entered through the subcutaneous tissue, much of it outside the operating room. This is why recording the infiltrated volume on the anesthetic record matters as much as recording the aspirate.
4. Volume threshold and setting
The American Society of Plastic Surgeons (ASPS) defines large-volume liposuction as a total aspirate greater than 5,000 mL — fat plus fluid — and recommends that these cases be performed in an acute-care hospital or an accredited or licensed facility, with overnight monitoring of vital signs and urine output. The recommendation rests on the size of the fluid shift and on its timing; bleeding with these techniques is marginal, and hemodynamic stability at the end of the procedure does not exclude later overload.
5. Expected urine output
Urine output in these series is high. A prospective study of 580 patients recorded a mean of 1.63 mL/kg/h (range 1.06 to 3.4 mL/kg/h); a review of extensive liposuction recorded 1.35 mL/kg/h in the operating room, 2.3 in the PACU and 1.4 on the ward, with an intraoperative fluid ratio of 1.66 and no pulmonary edema or cardiac decompensation. The values correspond to ongoing absorption of the wetting solution.
Where urine output is falling, giving volume without first assessing the cause is a recognized contributor to overload. Mechanical and hemodynamic causes are excluded before further fluid is given.
6. Lidocaine ceiling and infiltration volume
With the tumescent technique the maximum volume that can be infiltrated is set by the total lidocaine dose; the concentration of the solution, chosen by the surgeon, determines the volume that corresponds to that dose.
| Scenario | Ceiling |
|---|---|
| Tumescent, original description | 35 mg/kg |
| With liposuction, awake | 45 mg/kg |
| Under general anesthesia | 35 mg/kg (ASPS retains this limit) |
| Without liposuction | 28 mg/kg |
| Commercial lidocaine with epinephrine, undiluted | 7 mg/kg |
The 45 mg/kg figure comes from studies in awake patients; propofol and general anesthesia slow lidocaine metabolism, hence the lower limit. The 55 mg/kg figure still circulating in secondary sources is explicitly rejected by the publication cited to support it.
Dose-volume equivalence
For a 70 kg patient under general anesthesia, the 35 mg/kg ceiling corresponds to 2,450 mg of lidocaine: 2,450 mL of wetting solution at 1 g/L, or 4,900 mL at 0.5 g/L. If the ceiling is insufficient for the planned volume, the options are to reduce the concentration or to move to the superwet technique. Epinephrine at 1:1,000,000 delays absorption and underpins these ceilings; without it no maximum figure has been published.
Peak plasma concentration after discharge
In the original pharmacokinetic study, with 0.1% or 0.05% solutions and epinephrine 1:1,000,000, peak plasma concentration occurred 12 to 14 hours after infiltration began, and clinical anesthesia persisted for up to 18 hours. The risk window widens with the dose.
Perioral numbness, metallic taste, tinnitus, dizziness, blurred vision. Tremor and muscle twitching belong to a later stage and should not be attributed to postanesthetic shivering. Discharge instructions include how to recognize them.
7. Coordination with the surgeon
- Planned infiltration ratio, before induction.
- Lidocaine and epinephrine concentrations, and total volume to be infiltrated: these define the margin against the dose ceiling.
- Time infiltration begins, the reference point for the pharmacokinetic window.
- Actual aspirate volume at closure, separated into fat and fluid where possible.
Two points depend on the procedure: the wetting solution is best warmed, since large volumes at room temperature cause hypothermia in their own right; and where large-volume liposuction is combined with abdominoplasty, current recommendations advise against a single-stage operation and propose separating the procedures.
Key takeaways
- Aspirate: with the wet or tumescent technique it is largely wetting solution still being absorbed over hours; it is not replaced volume for volume.
- Additional crystalloid: 0.25 mL per mL of total aspirate above 5,000 mL.
- Large volume: total aspirate greater than 5,000 mL — fat plus fluid; acute-care hospital or accredited facility, with overnight monitoring of vital signs and urine output.
- Urine output: high during absorption of the wetting solution. Where it falls, exclude mechanical and hemodynamic causes before giving volume.
- Lidocaine: ceiling of 35 mg/kg under general anesthesia, with peak plasma concentration 12 to 14 hours after infiltration begins; discharge includes instruction on the prodrome.
Educational material for healthcare professionals. It does not replace individual clinical judgment or consultation of the current product information for each agent. Management in urgent or emergency surgery may differ from that described for elective procedures and should be individualized.
References
- Klein JA. Tumescent technique for regional anesthesia permits lidocaine doses of 35 mg/kg for liposuction. J Dermatol Surg Oncol. 1990;16(3):248-263. doi:10.1111/j.1524-4725.1990.tb03961.x
- Trott SA, Beran SJ, Rohrich RJ, Kenkel JM, Adams WP Jr, Klein KW. Safety considerations and fluid resuscitation in liposuction: an analysis of 53 consecutive patients. Plast Reconstr Surg. 1998;102(6):2220-2229. PMID 9811024
- Rohrich RJ, Leedy JE, Swamy R, Brown SA, Coleman J. Fluid resuscitation in liposuction: a retrospective review of 89 consecutive patients. Plast Reconstr Surg. 2006;117(2):431-435. doi:10.1097/01.prs.0000201477.30002.ce
- Basile AR, Fernandes F, Basile VV, Basile FV. Fluid resuscitation in liposuction: a prospective analysis of infiltrate-to-total aspirate ratios lower than used for the superwet technique. Aesthetic Plast Surg. 2006;30(6):659-665. doi:10.1007/s00266-006-0118-4
- Haeck PC, Swanson JA, Gutowski KA, et al; ASPS Patient Safety Committee. Evidence-based patient safety advisory: liposuction. Plast Reconstr Surg. 2009;124(4 Suppl):28S-44S. doi:10.1097/PRS.0b013e3181b52fcd
- Klein JA, Jeske DR. Estimated maximal safe dosages of tumescent lidocaine. Anesth Analg. 2016;122(5):1350-1359. doi:10.1213/ANE.0000000000001119
- Wang G, Cao WG, Zhao TL. Fluid management in extensive liposuction: a retrospective review of 83 consecutive patients. Medicine (Baltimore). 2018;97(41):e12655. doi:10.1097/MD.0000000000012655